Amorim A G, Carrington M, Miles M A, Barker D C, de Almeida M L
Universidade Federal de São Paulo, Escola Paulista de Medicina, Brazil.
Cell Stress Chaperones. 1996 Sep;1(3):177-87. doi: 10.1379/1466-1268(1996)001<0177:iotctr>2.3.co;2.
A Leishmania (Viannia) braziliensis (Lb) promastigote cDNA library in lambda gt11 was screened with patients' sera with the aim of identifying antigens specifically related to mucocutaneous leishmaniasis (MCL). One of the clones isolated, 133P, consistently reacted with MCL sera; it was sequenced and found to encode the C-terminal three-quarters of a protein belonging to the highly conserved Hsp70 family. Since Hsp70 proteins from different species tend to be less conserved through the C-terminal end, it was predicted that this region would be more antigenic and was likely to bear the discriminatory epitopes. In order to test this hypothesis, the N- and C-terminal halves of the polypeptide encoded by 133P, 133P-N and 133P-C, respectively, were expressed in Escherichia coli. Immunoblotting analysis demonstrated that 133P-C reacted more strongly with a pool of MCL sera than 133P-N, and both recombinant proteins reacted faintly with pools of cutaneous (CL) and visceral (VL) leishmaniasis sera. These results confirmed the predicted epitope location in the C-terminal region. The 133P-C fragment was also expressed as a fusion protein with glutathione-S-transferase (GST-133P-C), affinity-purified with glutathione-agarose and tested by ELISA with individual sera. From 46 Lb-infected patients, 41 sera (89%) were positive, no cross-reactivity was observed with healthy, Trypanosoma cruzior L. amazonensis-infected individuals. Despite a relatively high cross-reactivity with VL sera, the enhanced humoral response of MCL as compared with CL patients might be interesting for studies on disease aggravation.
为了鉴定与黏膜皮肤利什曼病(MCL)特异性相关的抗原,用患者血清筛选了λgt11载体中的巴西利什曼原虫(维安尼亚亚种)前鞭毛体cDNA文库。分离得到的一个克隆133P能持续与MCL血清发生反应;对其进行测序后发现,它编码一种属于高度保守的Hsp70家族的蛋白质的C端四分之三区域。由于来自不同物种的Hsp70蛋白在C端的保守性较低,因此推测该区域具有更强的抗原性,可能带有鉴别性表位。为了验证这一假设,分别在大肠杆菌中表达了由133P编码的多肽的N端和C端片段,即133P-N和133P-C。免疫印迹分析表明,133P-C与MCL血清池的反应比133P-N更强,且两种重组蛋白与皮肤利什曼病(CL)和内脏利什曼病(VL)血清池的反应都很微弱。这些结果证实了预测的表位位于C端区域。133P-C片段还被表达为与谷胱甘肽-S-转移酶的融合蛋白(GST-133P-C),用谷胱甘肽琼脂糖进行亲和纯化,并通过ELISA用个体血清进行检测。在46例感染巴西利什曼原虫的患者中,41份血清(89%)呈阳性,未观察到与健康人、克氏锥虫或亚马逊利什曼原虫感染个体的交叉反应。尽管与VL血清有相对较高的交叉反应,但与CL患者相比,MCL患者增强的体液反应可能对疾病加重的研究有意义。